Wells Fargo & Company Rhythm Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 29,474 shares of RYTM stock, worth $1.83 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,474

Previous 29,535 0.21%

Holding current value

$1.83 Million

Previous $1.21 Million 27.39%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$40.81 - $55.0 $2,489 - $3,355	-61 Reduced 0.21%	29,474 $1.54 Million
Q2 2024 Aug 13, 2024	BUY	$35.41 - $44.37 $90,295 - $113,143	2,550 Added 9.45%	29,535 $1.21 Million
Q1 2024 May 10, 2024	SELL	$39.12 - $52.44 $499,718 - $669,868	-12,774 Reduced 32.13%	26,985 $1.17 Million
Q4 2023 Feb 09, 2024	SELL	$21.39 - $49.64 $298,390 - $692,478	-13,950 Reduced 25.97%	39,759 $1.83 Million
Q3 2023 Nov 13, 2023	SELL	$15.81 - $27.8 $369,716 - $650,103	-23,385 Reduced 30.33%	53,709 $1.23 Million
Q2 2023 Aug 15, 2023	BUY	$16.32 - $21.15 $429,069 - $556,054	26,291 Added 51.75%	77,094 $1.27 Million
Q1 2023 May 12, 2023	BUY	$16.88 - $34.24 $743,732 - $1.51 Million	44,060 Added 653.42%	50,803 $906,000
Q4 2022 Feb 13, 2023	BUY	$22.21 - $30.25 $101,477 - $138,212	4,569 Added 210.17%	6,743 $196,000
Q3 2022 Nov 14, 2022	SELL	$4.3 - $30.85 $29,042 - $208,360	-6,754 Reduced 75.65%	2,174 $54,000
Q2 2022 Aug 12, 2022	SELL	$3.12 - $12.25 $2,776 - $10,902	-890 Reduced 9.06%	8,928 $37,000
Q1 2022 May 16, 2022	SELL	$6.13 - $12.24 $69,422 - $138,618	-11,325 Reduced 53.56%	9,818 $113,000
Q4 2021 Feb 14, 2022	BUY	$8.62 - $13.9 $163,176 - $263,127	18,930 Added 855.4%	21,143 $210,000
Q3 2021 Nov 15, 2021	SELL	$11.68 - $20.72 $88,277 - $156,601	-7,558 Reduced 77.35%	2,213 $29,000
Q2 2021 Aug 16, 2021	SELL	$18.52 - $22.55 $209,127 - $254,634	-11,292 Reduced 53.61%	9,771 $191,000
Q1 2021 May 13, 2021	SELL	$20.25 - $39.49 $206,914 - $403,508	-10,218 Reduced 32.67%	21,063 $448,000
Q4 2020 Feb 09, 2021	BUY	$21.17 - $32.61 $301,799 - $464,888	14,256 Added 83.74%	31,281 $930,000
Q3 2020 Nov 05, 2020	SELL	$18.13 - $30.61 $81,240 - $137,163	-4,481 Reduced 20.84%	17,025 $369,000
Q2 2020 Aug 13, 2020	BUY	$14.41 - $25.35 $93,549 - $164,572	6,492 Added 43.24%	21,506 $480,000
Q1 2020 May 14, 2020	BUY	$13.16 - $22.9 $197,584 - $343,820	15,014 New	15,014 $229,000

Others Institutions Holding RYTM

# of Institutions

192

Shares Held

67.3M

Call Options Held

834K

Put Options Held

78.6K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.46B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Rhythm Pharmaceuticals, Inc. Transaction History